✨
AI Summary
- Review of biopharma dealmaking in 2025.
- Analysis of rising deal values compared to 2024.
- Preview of 2026 dealmaking trends and outlook.
Guests on This Episode
JH
Joseph Haas
4 podcast appearances
RA
Roel Van den Akker
1 podcast appearance